Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway

Metabolism: Clinical and Experimental

Volumn 62, Issue 9, 2013, Pages 1239-1249

  Wang, Zhong Q ^a   Zhang, Xian H ^a   Yu, Yongmei ^a   Tipton, Russell C ^a   Raskin, Ilya ^b   Ribnicky, David ^b   Johnson, William ^a   Cefalu, William T ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

AMPK; FGF21; Insulin resistance; NAFLD; Obesity

Indexed keywords

ADIPONECTIN; AMP ACTIVATED PROTEIN KINASE ALPHA 1; ARTEMISIA SANTOLINAEFOLIA EXTRACT; ARTEMISIA SCOPARIA EXTRACT; CARNITINE PALMITOYLTRANSFERASE I; CHOLESTEROL; FAT DROPLET; FATTY ACID SYNTHASE; FIBROBLAST GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; PLANT EXTRACT; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE PHOSPHATASE 1B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTEMISIA SCOPARIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET INDUCED OBESITY MICE; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN TOLERANCE TEST; INTRACELLULAR SIGNALING; INTRAPERITONEAL INSULIN TOLERANCE TEST; LIPID DIET; LIPID LIVER LEVEL; LIVER; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL;

AMPK; FGF21; FGFR; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR RECEPTOR, NAFLD, NONALCOHOLIC FATTY LIVER DISEASE; INSULIN RESISTANCE; INTRAPERITONEAL GLUCOSE TOLERANCE TEST. AMPK, AMP-ACTIVATED PROTEIN KINASE; IPGTT; NAFLD; OBESITY;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ARTEMISIA; DIET, HIGH-FAT; FATTY LIVER; FIBROBLAST GROWTH FACTORS; INSULIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; PHYTOTHERAPY; PLANT EXTRACTS; SIGNAL TRANSDUCTION;

EID: 84883154801     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.03.004     Document Type: Article

References (43)

1. B.W. Smith, and L.A. Adams Non-alcoholic fatty liver disease Crit Rev Clin Lab Sci 48 2011 1 10
2. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 6037 2011 1519 1523
3. Z.B. Abid, M. Feki, A. Hedhili, and M.H. Hamdaoui Artemisia herba-alba Asso (Asteraceae) has equivalent effects to green and black tea decoctions on antioxidant processes and some metabolic parameters in rats Ann Nutr Metab 51 2007 216 222
4. M. Habib, and L. Waheed Evaluation of anti-nociceptive, anti-inflammatory and antipyretic activities of Artemisia scoparia hydromethanolic extract J Ethnopharmacol 145 2013 18 24
5. U.J. Jung, N.I. Baek, H.G. Chung, T.S. Jeong, and K.T. Lee Antilipogenic and hypolipidemic effects of ethanol extracts from two variants of Artemisia princeps Pampanini in obese diabetic mice J Med Food 12 2009 1238 1244
6. M. Sefi, H. Fetoui, M. Makni, and N. Zeghal Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats Food Chem Toxicol 48 2010 1986 1993
7. N. Hamza, B. Berke, C. Cheze, R. Le Garrec, and R. Lassalle Treatment of high fat diet induced type 2 diabetes in C57BL/6 J mice by two medicinal plants used in traditional treatment of diabetes in the east of Algeria J Ethnopharmacol 133 2011 931 933
8. N. Yamamoto, Y. Kanemoto, M. Ueda, K. Kawasaki, and I. Fukuda Anti-obesity and anti- diabetic effects of ethanol extract of Artemisia princeps in C57BL/6 mice fed a high-fat diet Food Funct 2 2011 45 52
9. Z.Q. Wang, D. Ribnicky, X.H. Zhang, I. Raskin, and Y. Yu Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture Metabolism 57 2008 S58 S64
10. Z.Q. Wang, D. Ribnicky, X.H. Zhang, A. Zuberi, and I. Raskin An extract of Artemisia dracunculus L. enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-A(y) mice J Nutr Biochem 22 2011 71 78
11. D.N. Obanda, A. Hernandez, D. Ribnicky, Y. Yu, and X.H. Zhang Bioactives of Artemisia dracunculus L. mitigate the role of ceramides in attenuating insulin signaling in rat skeletal muscle cells Diabetes 61 2012 597 605
12. F.S. Sharopov, and W.N. Setzer The essential oil of Artemisia scoparia from Tajikistan is dominated by phenyldiacetylenes Nat Prod Commun 6 2011 119 122
13. J.R. Hoult, and M. Paya Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential Gen Pharmacol 27 1996 713 722
14. H.P. Singh, S. Kaur, S. Mittal, D.R. Batish, and R.K. Kohli In vitro screening of essential oil from young and mature leaves of Artemisia scoparia compared to its major constituents for free radical scavenging activity Food Chem Toxicol 48 2010 1040 1044
15. Y.L. Chen, H.C. Huang, Y.I. Weng, Y.J. Yu, and Y.T. Lee Morphological evidence for the antiatherogenic effect of scoparone in hyperlipidaemic diabetic rabbits Cardiovasc Res 28 1994 1679 1685
16. M. Latha, L. Pari, K.M. Ramkumar, P. Rajaguru, and T. Suresh Antidiabetic effects of Scoparic acid D isolated from Scoparia dulcis in rats with streptozotocin-induced diabetes Nat Prod Res 23 2009 1528 1540
17. J.J. Diez, and P. Iglesias The role of the novel adipocyte-derived hormone adiponectin in human disease Eur J Endocrinol 148 2003 293 300
18. J. Fruebis, T.S. Tsao, S. Javorschi, D. Ebbets-Reed, and M.R. Erickson Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice Proc Natl Acad Sci U S A 98 2001 2005 2010
19. T. Kadowaki, and T. Yamauchi Adiponectin and adiponectin receptors Endocr Rev 26 2005 439 451
20. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, and N. Kubota The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946
21. A.H. Berg, T.P. Combs, X. Du, M. Brownlee, and P.E. Scherer The adipocyte-secreted protein Acrp30 enhances hepatic insulin action Nat Med 7 2001 947 953
22. T. Coskun, H.A. Bina, M.A. Schneider, J.D. Dunbar, and C.C. Hu Fibroblast growth factor 21 corrects obesity in mice Endocrinology 149 2008 6018 6027
23. Y. Zhao, J.D. Dunbar, and A. Kharitonenkov FGF21 as a therapeutic reagent Adv Exp Med Biol 728 2012 214 228
24. J. Folch, M. Lees, and G.H. Sloane Stanley A simple method for the isolation and purification of total lipides from animal tissues J Biol Chem 226 1957 497 509
25. T. Takamura, H. Misu, T. Ota, and S. Kaneko Fatty liver as a consequence and cause of insulin resistance: lessons from type 2 diabetic liver Endocr J 59 9 2012 745 763 [Epub 2012 Aug 12]
26. S. Zelber-Sagi, V. Ratziu, I. Zvibel, I. Goldiner, and L. Blendis The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population Eur J Gastroenterol Hepatol 24 2012 262 269
27. X. Ding, N.K. Saxena, S. Lin, A. Xu, and S. Srinivasan The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology Am J Pathol 166 2005 1655 1669
28. Z. Yang, X. Wang, J. Wen, Z. Ye, and Q. Li Prevalence of non-alcoholic fatty liver disease and its relation to hypoadiponectinaemia in the middle-aged and elderly Chinese population Arch Med Sci 7 2011 665 672
29. Y. Kamari, E. Peleg, M.O. Herman, M. Bursztyn, and E. Grossman The effect of chronic hyperinsulinemia on plasma adiponectin levels in Sprague-Dawley rats Horm Metab Res 41 2009 46 49
30. C. Winzer, O. Wagner, A. Festa, B. Schneider, and M. Roden Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus Diabetes Care 27 2004 1721 1727
31. M.P. Groeneveld, I. Huang-Doran, and R.K. Semple Adiponectin and leptin in human severe insulin resistance - diagnostic utility and biological insights Biochimie 94 2012 2172 2179
32. A.S. Lihn, S.B. Pedersen, and B. Richelsen Adiponectin: action, regulation and association to insulin sensitivity Obes Rev 6 1 2005 13 21
33. J.T. Brozinick, B.R. Roberts, and G.L. Dohm Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: potential role in insulin resistance Diabetes 52 2003 935 941
34. H. Liu, J.Y. Liu, X. Wu, and J.T. Zhang Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker Int J Biochem Mol Biol 1 2010 69 89
35. C. Yokoyama, X. Wang, M.R. Briggs, A. Admon, J. Wu, and X. Hua SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene Cell 75 1993 187 197
36. U. Christians, W. Jacobsen, and L.C. Floren Metabolism and drug interactions of 3-hydroxy-3- methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol Ther 80 1998 1 34
37. L. Abu-Elheiga, W. Oh, P. Kordari, and S.J. Wakil Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets Proc Natl Acad Sci U S A 100 2003 10207 10212
38. D. Stapleton, K.I. Mitchelhill, G. Gao, J. Widmer, and B.J. Michell Mammalian AMP-activated protein kinase subfamily J Biol Chem 271 1996 611 614
39. J. Thundyil, D. Pavlovski, C.G. Sobey, and T.V. Arumugam Adiponectin receptor signalling in the brain Br J Pharmacol 165 2012 313 327
40. S.A. Kliewer, and D.J. Mangelsdorf Fibroblast growth factor 21: from pharmacology to physiology Am J Clin Nutr 91 2010 254S 257S
41. T. Reinehr, J. Woelfle, R. Wunsch, and C.L. Roth Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis J Clin Endocrinol Metab 97 2012 2143 2150
42. X. Li, X. Fan, F. Ren, Y. Zhang, and C. Shen Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently Diabetes Res Clin Pract 93 2011 10 16
43. K. Eto, B. Tumenbayar, S. Nagashima, F. Tazoe, and M. Miyamoto Distinct association of serum FGF21 or adiponectin levels with clinical parameters in patients with type 2 diabetes Diabetes Res Clin Pract 89 2010 52 57